NEW YORK, July 28 (Reuters) - Allergan Inc (AGN.N) on Wednesday said its drug Ozurdex has become the first drug in Europe approved to treat a eyesight-endangering condition in which fluid builds up in the retina because of a clogged vein.
NEW YORK, July 28 (Reuters) - Allergan Inc (AGN.N) on Wednesday said its drug Ozurdex has become the first drug in Europe approved to treat a eyesight-endangering condition in which fluid builds up in the retina because of a clogged vein.
